TABLE 3.

Comparison of clinical courses in MR patients and MS patients

Characteristic	MR patients (n = 11)	MS patients (n = 26)	P
Febrile days
Median (range)	8 (4-19)	5 (2-9)	0.019
Mean	9.3	5.5
Febrile days during macrolide administration
Median (range)	3 (1-11)	1 (1-5)	0.002
Mean	4.3	1.4
Febrile days before macrolide administration
Median (range)	3 (1-10)	4 (1-8)	0.402
Mean	3.8	4.1
No. of patients with a febrile period exceeding 48 h after macrolide administration (%)	8 (72.7)	5 (19.2)	0.006
No. of patients with a change of prescription after macrolide administration (%)	7 (63.6)	1 (3.8)	<0.001